Schedule 13G ownership disclosure
VINCERX PHARMA INC
Security class unavailable · CUSIP: 92731L106
Event date: 2022-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,492,771
- Percent of class
- 7.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001387131-23-001893
- Form type
- SC 13G
- Filer
- Affinity Asset Advisors, LLC
- CIK
- CIK 1773195
- Filed
- Feb 13, 2023
- Reporting period
- Dec 31, 2022
- Description
- Schedule 13G beneficial ownership